Contact

The Benefits of Amniotic Fluid in Wound Care

Research has explored the safe, effective use of amniotic fluid in wound care. The autologous use of amniotic fluid may represent a major step forward for healing the cesarean wound.

Biological Properties of Amniotic Fluid (AF)

The benefits of amniotic fluid are well established. Amniotic fluid has been used in surgical specialties for its anti-inflammatory, anti-adhesive, antimicrobial and cellular rich properties.

In wound care, the use of amniotic fluid promotes:

Cellular Regeneration Icon

Cellular Regeneration

AF provides growth factors (EGF, TGF-β, VEGF) and hyaluronic acid that encourage fibroblast proliferation and controlled collagen deposition.1,2

Infection Control

AF contains innate antimicrobial proteins that inhibit Gram-positive and Gram-negative bacteria, as well as immunomodulatory cytokines that prevent excessive inflammation.3
Exosome Delivery Icon

Exosome Delivery

AF naturally contains exosomes carrying microRNAs, proteins, and lipids that regulate angiogenesis and tissue repair.4
Coagulation Support Icon

Coagulation Support

Hyaluronic acid and extracellular vesicles in AF stabilize the local environment, potentially helping to integrate clotting with tissue regeneration.5

The Autologous Use of Amniotic Fluid in Cesarean Care

The solution to better healing doesn’t come from a lab; it comes from the patient herself. Amniotic fluid is naturally available for autologous use.

With Autologous Amniotic Fluid (AAF), providers can offer a natural, homologous, patient-focused approach to cesarean wound care.

See Supporting Research

AAF’s Relevance in the Cesarean Wound Environment

The use of Autologous Amniotic Fluid is part of a multifunctional therapeutic strategy for cesarean section and surgical wound care.

Application With CaCl2

Studies suggest that the combined application of AAF with 10% calcium chloride (CaCl2) solution may enhance the delivery of therapeutic agents to the cesarean wound and create a favorable microenvironment for defense, repair and fibrotic reduction.

Improved defense against SSIs

CaCl₂ weakens bacterial defenses while AAF delivers antimicrobial proteins, creating a two-tier barrier against surgical site infections post-cesarean.3,8

Enhanced exosome delivery
CaCl₂ improves delivery efficiency, ensuring AAF’s exosomes penetrate recipient cells more effectively, amplifying regenerative signals at the wound site.4,9

Balanced healing
CaCl₂ establishes rapid hemostasis, while AAF modulates the healing microenvironment—preventing excessive fibrosis and promoting organized repair.5,10

Reduced scarring
CaCl₂ promotes cellular migration and regeneration, while AAF supplies regenerative signals and structural molecules for balanced wound closure.1,2,6,7

Extended Release With Hydrogel

Hydrogels are a popular vehicle for the suspension and delivery of proteins, growth factors, and exosomes. When hydrated with amniotic fluid, Ribbon dressing allows for the extended protection and delivery of therapeutic properties to the cesarean wound site.

A moist wound environment
Hydrogel dressing promotes a moist, undisturbed wound environment that mimics the function of the epidermis and promotes healing.11

Extended delivery of growth factors
Hydrogel dressing can stay in place for several days, for a gradual, controlled delivery of antibacterial agents, growth factors, and other possible active substances, if combined with AAF by a physician.12

Localized potency

Introducing autologous amniotic fluid into a hydrogel dressing allows the physician to create a highly sophisticated and biologically active wound dressing.

Antibacterial protection
Chitosan, a native polysaccharide that is a common component in hydrogels, has antibacterial and hemostatic properties and the ability to promote granulation tissue growth, lending additional protection for wounds.13

Explore the Research

Access our library of studies, findings, and clinical data related to the use of amniotic fluid and its autologous use in cesarean wound care.

Access Research
Sources
  1. Niknejad H, et al. Properties of the amniotic membrane. Eur Cell Mater. 2008;15:88-99.
  2. Gnecchi M, et al. Paracrine mechanisms in stem cell therapy. Circ Res. 2008;103(11):1204-1219.
  3. Kjaergaard N, et al. Antibacterial properties of human amniotic membrane. Acta Obstet Gynecol Scand. 2001;80(12):1069-1075.
  4. Théry C, et al. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569-579.
  5. Koob TJ, et al. Amniotic membrane as a biomaterial. Biomater Sci. 2014;2(11):1554-1564.
  6. Clapham DE. Calcium signaling. Cell. 2007;131(6):1047-1058.
  7. Martin P. Wound healing—aiming for perfect skin regeneration. Science. 1997;276(5309):75-81.
  8. Lambert PA. Cellular impermeability and uptake of biocides. J Appl Microbiol. 2002;92(s1):46S-54S.
  9. Pickering JW, et al. Calcium enhances uptake of extracellular vesicles. J Extracell Vesicles. 2020;9(1):1702332.
  10. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958-965.
  11. Sibbald RG, Niezgoda JA & Ayello EA. (2020). Wound Debridement. In: S Baranoski & EA Ayello (Eds.), Wound Care Essentials: Practice Principles. 5th ed. Wolters Kluwer: 163-184.
  12. Elangwe, C. N., Morozkina, S. N., Olekhnovich, R. O., Krasichkov, A., Polyakova, V. O., & Uspenskaya, M. V. (2022). A Review on Chitosan and Cellulose Hydrogels for Wound Dressings. Polymers, 14(23), 5163. https://doi.org/10.3390/polym14235163
  13. Feng P, Luo Y, Ke C, Qiu H, Wang W, Zhu Y, Hou R, Xu L and Wu S (2021) Chitosan-Based Functional Materials for Skin Wound Repair: Mechanisms and Applications. Front. Bioeng. Biotechnol. 9:650598. doi: 10.3389/fbioe.2021.650598
Contact

Want to Learn More?

Connect with the CeaLogic team to request additional provider resources, product information, and educational materials.

Contact Us